Science Explorer Back to mapMap
Discussion
Company · Doylestown · United States

Pharmabridge (United States)

pharmabridgegroup.comROR OpenAlex
Research works
1
◆ 0% vs 2018-21
Citations
30
23.4 per fractional work
Top-10% rate
0.0%
all institutions 10.0%
Open access
54%
world 40%
International
69%
world 18%
Pharmabridge (United States)

Not ranked overall: Pharmabridge (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Pharmabridge (United States) work in?

In all years, 50% of research at Pharmabridge (United States) is in Health Sciences, 33% in Life Sciences. Its largest fields are Medicine (50%), Immunology and Microbiology (25%), Biochemistry, Genetics and Molecular Biology (8%).

Health Sciences: 1 fractional works · 50.0% of its workMedicine: 1 fractional works · 50.0% of its workLife Sciences: 0 fractional works · 33.3% of its workImmunology and Microbiology: 0 fractional works · 25.0% of its workBiochemistry, Genetics and Molecular Biology: 0 fractional works · 8.3% of its workPhysical Sciences: 0 fractional works · 16.7% of its workChemistry: 0 fractional works · 8.3% of its workEnvironmental Science: 0 fractional works · 8.3% of its workALL ITS WORKPharmabridge(United States)1fractional works, all years
Life Sciences33%Physical Sciences17%Health Sciences50%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 5 fields, with their numbers
    1. Medicine150.0%
    1. Immunology and Microbiology025.0%
    2. Biochemistry, Genetics and Molecular Biology08.3%
    1. Chemistry08.3%
    2. Environmental Science08.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from Pharmabridge (United States)?

The most cited paper from Pharmabridge (United States) is "Design, Synthesis, and Biological Evaluation of Triazolo-pyrimidine Derivatives as Novel Inhibitors of Hepatitis B Virus Surface Antigen (HBsAg) Secretion" (Wenquan Yu, Cally Goddard, Elizabeth Clearfield et al., 2011), with 122 citations. Next come "Novel Imino Sugar Derivatives Demonstrate Potent Antiviral Activity against Flaviviruses" (86) and "Investigation of deltamethrin resistance in salmon lice (Lepeophtheirus salmonis) provides no evidence for roles of mutations in voltage‐gated sodium channels" (5).

Most cited papers
#PaperReleasedCitations
1 Design, Synthesis, and Biological Evaluation of Triazolo-pyrimidine Derivatives as Novel Inhibitors of Hepatitis B Virus Surface Antigen (HBsAg) Secretion Wenquan Yu, Cally Goddard, Elizabeth Clearfield et al. · Journal of Medicinal Chemistry Open access 25 Jul 2011 122
2 Novel Imino Sugar Derivatives Demonstrate Potent Antiviral Activity against Flaviviruses Jinhong Chang, Lijuan Wang, Dongling Ma et al. · Antimicrobial Agents and Chemotherapy Open access 18 Feb 2009 86
3 Investigation of deltamethrin resistance in salmon lice (Lepeophtheirus salmonis) provides no evidence for roles of mutations in voltage‐gated sodium channels Claudia Tschesche, Michaël Bekaert, David I. Bassett et al. · Pest Management Science Open access Oct 2020 5
4 Effect of acoramidis on risk of death and heart problem-related hospitalizations in people with transthyretin amyloid cardiomyopathy: a plain language summary Daniel P. Judge, Kevin M. Alexander, Francesco Cappelli et al. · Future Cardiology Open access 3 Jul 2026 0
5 Plain language summary of how acoramidis affects the total number of heart problems over time in people with ATTR-CM: findings from the ATTRibute-CM study Ahmad Masri et al. · Future Cardiology Open access 3 Aug 2026 0
All 9 most cited papers, with filters and sorting

Which research topics does Pharmabridge (United States) publish most on?

By volume in 2022-now: Pharmaceutical Practices and Patient Outcomes.

  1. 1 Pharmaceutical Practices and Patient Outcomes Geriatrics and Gerontology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available53.6%not open46.4%

World: 40% of research is openly available.

with international co-authors69.3%domestic only30.7%

World: 18% is written across borders.

How has Pharmabridge (United States)'s research output changed?

Output in 2022-2025 was 0% higher than in 2018-2021.

201020152020

Other research institutions in Doylestown

All research institutions in Doylestown

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Pharmabridge (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.